Thrombocytopenia and complement activation under recombinant TNFα/IFNγ therapy in man

Annals of Hematology

Volumn 74, Issue 4, 1997, Pages 179-184

  Michelmann, I ^a   Bockmann D ^a   Nurnberger W ^a   Eckhof Donovan, S ^a   Burdach, S ^a   Gobel U ^a  

^a UNIVERSITY HOSPITAL DÜSSELDORF   (Germany)

Author keywords

Complement activation; Ewing tumor; Interferon gamma; Platelet biology; Tumor necrosis factor alpha

Indexed keywords

RECOMBINANT ALPHA INTERFERON; RECOMBINANT GAMMA INTERFERON;

ADOLESCENT; ADULT; ARTICLE; BLEEDING; CASE REPORT; COMPLEMENT ACTIVATION; CONTROLLED STUDY; EWING SARCOMA; FEMALE; HUMAN; HUMAN CELL; INTRAVENOUS DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ANTITHROMBIN III; BLOOD PLATELETS; COMPLEMENT ACTIVATION; COMPLEMENT MEMBRANE ATTACK COMPLEX; FEMALE; FIBRINOGEN; HEMOSTASIS; HUMANS; INFANT; INTERFERON TYPE II; LEUKOCYTE COUNT; MALE; PEPTIDE HYDROLASES; PLATELET AGGREGATION; PLATELET COUNT; RECOMBINANT PROTEINS; REFERENCE VALUES; THROMBOCYTOPENIA; TUMOR NECROSIS FACTOR-ALPHA;

EID: 1842336908     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002770050279     Document Type: Article

References (27)

1. Aderka D (1991) Role of tumor necrosis factor in the pathogenesis of intravascular coagulopathy of sepsis: potential new therapeutic implications. Israel J Med Sci 27:52-60
2. Bauer KA, ten Cate H, Barzegar S, Spriggs DR, Sherman ML, Rosenberg RD (1989) Tumor necrosis factor infusions have a procoagulant effect on the hemostatic mechanism of humans. Blood 74:165-169
3. Bazzoni F, Beutler B (1996) The tumor necrosis factor ligand and receptor families. N Engl J Med 334:1717-1725
4. Bordier C (1981) Phase separation of integral membrane proteins in Triton X-114 solution. J Biol Chem 256:1604-1607
5. Born GVR, Cross HJ (1963) The aggregation of blood platelets. J Physiol 168:178-195
6. Burdach S, Jürgens H, Peters C, Nürnberger W, Mauz-Körholz C, Körholz D, Paulussen M, Pape H, Koszielniak E, Gadner H, Göbel U (1993) Myeloablative radiochemotherapy and hematopoietic stem cell rescue in patients with poor-prognosis Ewing's sarcoma. J Clin Oncol 11:1482-88
7. Deehan DJ, Heys SD, Simpson W, Herriot R, Broom J, Eremin O (1994) Correlation of serum cytokine and acute phase reactant levels with alterations in weight and albumin in patients receiving immunotherapy with recombinant IL-2. Clin Exp Immunol 95:366-372
8. Flier JS, Underbill LH (1993) Platelet-endothelium interactions. N Engl J Med 328:628-635
9. Freedmann MH, Cohen A, Grundberger T, Bunin N, Luddy RE, Saunders EF, Shahidi N, Lau A, Estrov Z (1992) Central role of tumour necrosis factor, GM-CSF, and interleukin 1 in the pathogenesis of juvenile chronic myelogenous leukaemia. Br J Hematol 80:40-48
10. Gamm H, Lindemann A, Mertelsmann R, Herrmann F (1991) Phase I trial of recombinant human tumor necrosis factor alpha in patients with advanced malignancy. Eur J Cancer 27:856-863
11. Gardlund B, Sjolin J, Nilsson A, Roll M, Wickerts CJ, Wretlind B (1995) Plasma levels of cytokines in primary septic shock in humans: correlation with disease severity. J Infect Dis 172:296-301
12. Grier HE, Civin CI (1992) Acute and chronic myeloproloferative disorders and myelodysplasia. In: Nathan DG, Oski FA (eds) Hematology of infancy and childhood. Saunders, Philadelphia, pp1293-1295
13. Hinsberg VWM van, Kooistra T, Kluft C, Dooijewaard G, Sherman ML, Nieuwnhuizen W (1990) Progress of fibrinolysis during tumor necrosis factor infusions in humans. Concomitant increase in tissue-type plasminogen activator, plasminogen activator inhibitor type-1, and fibrin-(ogen) degradation products. Blood 76:2284-2289
14. Jürgens H (1994) Ewing's sarcoma and peripheral primitive neuroectodermal tumor. Curr Opin Oncol 6:391-396
15. Jürgens H, Bier V, Dunst J, Harms D, Jobke A, Kotz R, Kühl J, Müller-Weihrich S, Ritter J, Salzer-Kuntschik M, Sauer R, Sternschulte W, Treuner J, Voûte PA, Weinel P, Winkelmann W, Winkler K, Göbel, U (1988) Die GPO cooperativen Ewing-Sarkom Studien Cess 81/86: Bericht nach 6 1/2 Jahren. Klin Padiatr 200:243-252
16. Kirchhofer D, Tschopp TB, Hadvary P, Baumgartner HR (1994) Endothelial cells stimulated with tumor necrosis factor-alpha express varying amounts of tissue factor resulting in inhomogeneous fibrin deposition in a native blood flow system. Effects of thrombin inhibitors. J Clin Invest 93:2073-2083
17. Mollnes TE, Lea T, Frøland SS, Harboe M (1985) Quantification of the terminal complement complex in human plasma by an enzyme-linked immunosorbent assay based on monoclonal antibodies against a neoantigen of the complex. Scand J Immunol 22:197-202
18. Nawroth PP, Stern DM (1987) Tumor necrosis factor/cachectin-induced modulation of endothelial cell hemostatic properties. Onkologie 10:254-258
19. Nürnberger W, Kruck H, Manz-Körholz C, Burdach S, Göbel U (1997) Humoral coagulation and early complications after allogeneic bone marrow transplantation. Klin Pädiatr 21 (in press)
20. Nürnberger W, Jäger M, Michelmann I, Burdach S, Göbel U (1995) Alterations of humoral coagulation factors and platelets in patients with capillary leakage syndrome. Thromb Haemost 73:1359 (abstract)
21. Nürnberger W, Schneider EM, Michelmann I, Radis F, Scharf RE, Göbel U (1996) Plasminogen activator inhibitor-1 (PAI-1) in cultered microvascular endothelial cells. Ann Hematol 72 [Suppl 1]:A 28 (abstract)
22. Piguet PF, Grau GE, Allet B, Vasalli P (1987) Tumor necrosis factor/cachectin is an effector of skin and gut lesions of the acute phase of graft versus host disease. J Exp Med 166:1280-1287
23. Shattil SJ, Cunningham M, Wiedmer T, Zhao J, Sims PJ, Brass LF (1992) Regulation of glycoprotein IIb-IIIa receptor function studied with platelets permeabilized by the poreorming complement proteins C5b-9. J Biol Chem 267:18424-18431
24. Sims PJ, Wiedmer T (1991 ) The response of human platelets to activated components of the complement system. Immunol Today 12:338-342
25. Tartaglia LA, Goeddel DV (1992) Two TNF receptors. Immunol Today 13:151-153
26. van der Poll T, Levi M, Buller HR, van Deventer SJH, de Broer JP, Hack CE, ten Cate JW (1991) Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729-732
27. van Valen F, Winkelmann W, Burdach St, Göbel U, Jürgens H (1993) Interferon-γ and tumor necrosis factor-α induce a synergistic antiproliferative response in human Ewing's sarcoma cells in vitro. J Cancer Res Clin Oncol 119:615-621